Literature DB >> 4808927

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.

R Sherwin, P Joshi, R Hendler, P Felig, H O Conn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4808927     DOI: 10.1056/NEJM197401312900502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

Review 1.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

3.  Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

Authors:  G Marchesini; M Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

4.  Insulin and glucagon concentrations in the portal and peripheral blood in liver-injured and partially hepatectomized rats.

Authors:  A Watanabe; T Higashi; S Hayashi; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1982

5.  Hepatic and renal metabolism before and after portasystemic shunts in patients with cirrhosis.

Authors:  O E Owen; M A Mozzoli; F A Reichle; T H Kreulen; R S Owen; G Boden; M Polansky
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

6.  Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.

Authors:  T J Johnson; E M Quigley; T E Adrian; G Jin; L F Rikkers
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Tyramine kinetics and metabolism in cirrhosis.

Authors:  B A Faraj; J T Fulenwider; E B Rypins; B Nordlinger; G L Ivey; R D Jansen; F M Ali; V M Camp; M Kutner; F Schmidt; D Rudman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.

Authors:  O E Owen; F A Reichle; M A Mozzoli; T Kreulen; M S Patel; I B Elfenbein; M Golsorkhi; K H Chang; N S Rao; H S Sue; G Boden
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Effect of branched chain amino acid infusions on body protein metabolism in cirrhosis of liver.

Authors:  P D Wright; J D Holdsworth; P Dionigi; M B Clague; O F James
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

10.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.